Prescription Medications with Generic Names Beginning ‘D’, Page 5

Page 5 of 429 « First Page « … 3 4 5 6 7 … 10 15 20 25 30 … » Last Page »

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Hikma Pharmaceuticals USA Inc.22 December 2021

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Actavis Pharma, Inc.2 December 2021

Dalfampridine

Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking…

Mylan Pharmaceuticals Inc.13 September 2022

DALFAMPRIDINE

Dalfampridine extended-release tablet is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed…

Micro Labs Limited28 November 2022

AMPYRA (Dalfampridine)

AMPYRA is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14). ]…

Acorda Therapeutics, Inc.23 January 2023

Page 5 of 429 « First Page « … 3 4 5 6 7 … 10 15 20 25 30 … » Last Page »

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.